Chronic Obstructive Pulmonary Disease (COPD) research at ResMed

At ResMed, we strive to develop our patient expertise and experience. With our programme to research clinical areas related to sleep-disordered breathing, we aim to further develop our in-depth knowledge on sleep and respiratory disorders. That’s why we support and actively engage in research initiatives on COPD.

ResMed is supporting multiple global trials investigating morbidity and mortality benefits, as well as biomarkers, quality of life and other outcomes in COPD patients treated with non-invasive ventilation (NIV).

eCOPD is one of our studies which aims to evaluate the long-term efficacy and benefits of telemonitored NIV treatment on COPD patients. We expect to test 80 patients with a one-year follow-up.

ResMed is also performing clinical trials that evaluate the use of iVAPS technology in COPD patients, with several studies to be published in 2014.

For clinical literature on sleep apnoea and COPD, consult our dedicated ResMed page